出版社 | Grand View Research |
出版年月 | 2025年2月 |
Automated Microbiology Market Size, Share & Trends Analysis Report
The global automated microbiology market size is anticipated to reach USD 13.73 billion by 2030 and is anticipated to expand at a CAGR of 10.69% from 2025 to 2030, according to a new report by Grand View Research, Inc. The global automated microbiology market is expected to grow over the forecast period owing to the increasing prevalence of pathogen-induced diseases.
Grand View Research, Inc. の新しいレポートによると、世界の自動化微生物学市場規模は 2030 年までに 137 億 3,000 万米ドルに達し、2025 年から 2030 年にかけて 10.69% の CAGR で拡大すると予想されています。病原体誘発性疾患の蔓延の増加により、世界の自動化微生物学市場は予測期間中に成長すると予想されています。
In recent years, the identification of pathogens with the help of automated microbiology has generated huge momentum, as it helps in the early detection of various infectious agents such as parasites, viroid, fungi, prion, bacterium, and viruses. These agents cause severe diseases like rubella, ebola, chickenpox, measles, mumps, influenza, and smallpox. Automated microbiology has gained importance as a result of outbreaks of new diseases as a consequence of adapting and mutating bacteria. The ability to promptly respond to the increasing demand for public health lies in offering accurate, better, and rapid identification of diseases and causative pathogens.
近年、自動微生物学による病原体の特定は、寄生虫、ウイロイド、真菌、プリオン、細菌、ウイルスなどのさまざまな感染性因子の早期発見に役立つため、大きな勢いを生み出しています。これらの因子は、風疹、エボラ、水痘、麻疹、おたふく風邪、インフルエンザ、天然痘などの重篤な疾患を引き起こします。自動微生物学は、細菌の適応と変異の結果として新しい疾患が発生した結果、重要性を増しています。公衆衛生に対する高まる需要に迅速に対応する能力は、疾患と原因となる病原体の正確でより優れた迅速な特定を提供することにあります。

Automated Microbiology Market Report Scope
Report Attribute | Details |
Market size in 2025 | USD 8.27 billion |
Revenue Forecast in 2030 | USD 13.73 billion |
Growth rate | CAGR of 10.69% from 2025 to 2030 |
Actual data | 2018 – 2024 |
Forecast period | 2025 – 2030 |
Quantitative units | Revenue in USD million/billion, and CAGR from 2025 to 2030 |
Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered | Product, automation type, application, end-use, region |
Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
Country scope | U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait |
Key companies profiled | BD; QIAGEN; Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Danaher; Merck KGaA; bioMérieux; Abbott; DiaSorin S.p.A.; BioRad Laboratories, Inc. |
Customization scope | Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |